Inhibition of cellular RNA polymerase II transcription by delta antigen of hepatitis delta virus

Virology

Volumn 247, Issue 2, 1998, Pages 178-188

  Lo, Kiersten ^a   Sheu, Gwo Tarng ^a   Lai, Michael M C ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ENZYME INHIBITION; HELA CELL; HEPATITIS DELTA VIRUS; NONHUMAN; PRIORITY JOURNAL; RNA REPLICATION; RNA SYNTHESIS; TRANSCRIPTION REGULATION; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION;

DELTA VIRUS; HEPATITIS DELTA VIRUS; RNA VIRUSES; VIROIDS;

EID: 0032146345     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9253     Document Type: Article

References (56)

1. Boyer T. G., Berk A. J. Functional interaction of adenovirus E1A with holo-TFIID. Genes Dev. 7:1993;1810-1823.
2. Brazas R., Ganem D. A cellular homology of hepatitis delta antigen: Implications for viral replication and evolution. Science. 274:1996;90-94.
3. Cahill M. A., Ernst W. H., Janknecht R., Nordheim A. Regulatory squelching. FEBS Lett. 344:1994;105-108.
4. Chang F.-L., Chen P.-J., Tu S.-J., Wang C.-J., Chen D.-S. The large form of hepatitis δ antigen is crucial for assembly of hepatitis δ virus. Proc. Natl. Acad. Sci. USA. 88:1991;8490-8494.
5. Chang M.-F., Baker S. C., Soe L. H., Kamahora T., Keck J. G., Makino S., Govindarajan S., Lai M. M. C. Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity. J. Virol. 62:1988;2403-2410.
6. Chang M.-F., Sun C.-Y., Chen C.-J., Chang S.-C. Functional motifs of delta antigen essential for RNA binding and replication of hepatitis delta virus. J. Virol. 67:1993;2529-2536.
7. Chao M., Hsieh S.-Y., Taylor J. Role of two forms of hepatitis delta virus antigen: Evidence for a mechanism of self-limiting genome replication. J. Virol. 64:1990;5066-5069.
8. Chao M., Hsieh S.-Y., Taylor J. The antigen of hepatitis delta virus: Examination ofin vitro. J. Virol. 65:1991;4057-4062.
9. Clark M. E., Lieberman M., Berk A. J., Dasgupta A. Direct cleavage of human TATA-binding protein by poliovirus protease 3Cin vivoin vitro. Mol. Cell. Biol. 13:1993;1232-1237.
10. Cole S. M., Gowans E. J., Macnaughton T. B., Hall P. D. M., Burrell C. J. Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen. Hepatology. 13:1990;845-851.
11. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
12. Dingermann T., Sharp S., Schaack J., Söll D. Stable transcription complex formation of eukaryotic tRNA genes is dependent on a limited separation of the two intragenic control regions. J. Biol. Chem. 258:1983;10395-10402.
13. Dinter-Gottlieb, G. 1995, The Unique Hepatitis Delta Virus, R. G. Landes Company, Austin.
14. Fields, B. N. Knipe, D. M. Howley, P. M. 1996, Fields Virology, Lippencott-Raven Publishers, Philadelphia.
15. Flores R. Synthesis of RNAs specific to citrus exocortis viroid by a fraction rich in nuclei from infectedGynura aurantiaca: J. Gen. Virol. 70:1989;2695-2706.
16. Fu T.-B., Taylor J. The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates. J. Virol. 67:1993;6965-6972.
17. Fujii M., Tsuchiya H., Chuhjo T., Akizawa T., Seiki M. Interaction of HTLV-1 Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev. 6:1992;2066-2076.
18. Gill G., Ptashne M. Negative effect of the transcriptional activator GAL4. Nature. 334:1988;721-724.
19. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
20. Hoofnagle J. H. Type D (delta) hepatitis. J. Am. Med. Assoc. 261:1989;1321-1325.
21. Hwang S. B., Lai M. M. C. A unique conformation at the carboxyl terminus of the small hepatitis delta antigen revealed by a specific monoclonal antibody. Virology. 193:1993;924-931.
22. Hwang S. B., Lee C. Z., Lai M. M. C. Hepatitis delta antigen expressed by recombinant baculoviruses: Comparison of biochemical properties and post-translational modifications between the large and small forms. Virology. 190:1992;413-422.
23. Jeng K.-S., Su P.-Y., Lai M. M. C. Hepatitis delta antigens enhance the ribozyme activities of hepatitis delta virus RNAin vivo. J. Virol. 70:1996;4205-4209.
24. Kos A., Dijkema R., Arnberg A. C., van der Merde P. H., Schellekens H. The HDV possesses a circular RNA. Nature. 323:1986;558-560.
25. Kuo M. Y.-P., Chao M., Taylor J. Initiation of replication of the human hepatitis delta virus genome from cloned DNA: Role of delta antigen. J. Virol. 63:1989;1945-1950.
26. Landschultz W. H., Johnson P. F., Mcknight S. L. The leucine-zipper: A hypothetical structure common to a new class of DNA binding proteins. Science. 240:1988;1759-1764.
27. Li H.-P., Zhang X., Duncan R., Comai L., Lai M. M. C. Heterogeneous nuclear ribonucleoprotein A1 binds to the transcription-regulatory region of mouse hepatitis virus RNA. Proc. Natl. Acad. Sci. USA. 94:1997;9544-9549.
28. Lin J.-H., Chang M.-F., Baker S. C., Govindarajan S., Lai M. M. C. Characterization of hepatitis delta antigen: Specific binding to hepatitis delta virus RNA. J. Virol. 64:1990;4051-4058.
29. Lo K., Landau N. R., Smale S. T. LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes. Mol. Cell. Biol. 11:1991;5229-5243.
30. Lo K., Smale S. T. Generality of a functional initiator consensus sequence. Gene. 182:1996;13-22.
31. Macnaughton T. B., Gowans E. J., Jilbert A. R., Burrell C. J. Hepatitis delta virus RNA, protein synthesis and associated cytotoxicity in a stably transfected cell line. Virology. 177:1990a;692-698.
32. Macnaughton T. B., Gowans E. J., McNamara S. P., Burrell C. J. Hepatitis δ antigen is necessary for access of hepatitis δ virus RNA to the cell transcriptional machinery but is not part of the transcriptional complex. Virology. 184:1991;387-390.
33. Macnaughton T. B., Gowans E. J., Reinboth B., Jilbert A. R., Burrell C. J. Stable expression of hepatitis delta virus antigen in a eukaryotic cell line. J. Gen. Virol. 71:1990b;1339-1345.
34. Makino S., Chang M. F., Shieh C. K., Kamahora T., Vannier D. M., Govindarajan S., Lai M. M. C. Molecular cloning and sequencing of a human hepatitis delta virus RNA. Nature. 329:1987;343-346.
35. Martin K. J., Lillie J. W., Green M. R. Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets. Nature. 346:1990;147-152.
36. Parker B. A., Stark G. R. Regulation of simian virus 40 transcription: Sensitive analysis of the RNA species present early in infections by virus or viral DNA. J. Virol. 31:1979;360-369.
37. Pfitzner E., Sak A., Ulber V., Ryffel G. U., Klein-Hitpass L. Recombinant activation domains of virion protein 16 and human estrogen receptor generate transcriptional interferencein vitro. Mol. Endocrinol. 7:1993;1061-1071.
38. Plevy S. E., Gemberling J. H. M., Hsu S., Dorner A. J., Smale S. T. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: Evidence of functional synergy between C/EBP and Rel proteins. Mol. Cell. Biol. 17:1997;4572-4588.
39. Ptashne M. How eukaryotic transcriptional activators work. Nature. 335:1988;683-689.
40. Rizzetto M. The delta agent. Hepatology. 3:1983;729-737.
41. Ryu W.-S., Bayer M., Taylor J. Assembly of hepatitis delta virus particles. J. Virol. 66:1992;2310-2315.
42. Sadowski I., Ma J., Triezenberg S., Ptashne M. GAL4-VP16 is an unusually potent transcriptional activator. Nature. 335:1988;563-564.
43. Sambrook, J. Fritsch, E. F. Maniatis, T. 1989, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
44. Smale S. T., Baltimore D. The "initiator" as a transcription control element. Cell. 57:1989;103-113.
45. Smale S. T., Tjian R. Transcription of herpes simplex virus tk sequences under the control of wild-type and mutant human RNA polymerase I promoters. Mol. Cell. Biol. 5:1985;352-362.
46. Sureau C., Moriarty A. M., Thornton G. B., Lanford R. E. Production of infectious hepatitis delta virusin vitro. J. Virol. 66:1992;1241-1245.
47. Triezenberg S. J., Kingsbury R. C., McKnight S. Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. Genes Dev. 2:1988;718-729.
48. Wang J.-G., Lemon S. M. Hepatitis delta virus antigen forms dimers and multimeric complexesin vivo. J. Virol. 67:1993;446-454.
49. Wang K. S., Choo Q. L., Weiner A. J., Ou J. H., Najarian R. C., Thayer R. M., Mullenbach G. T., Denniston K. J., Gerin J. L., Houghton M. Structure, sequence and expression of the hepatitis delta viral genome. Nature. 323:1986;508-514.
50. Wei Y., Ganem D. Activation of heterologous gene expression by the large isoform of hepatitis delta antigen. J. Virol. 72:1998;2089-2096.
51. Wu J.-C., Chen P.-J., Kuo M. Y.-P., Lee S.-D., Chen D.-S., Ting L. P. Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line. J. Virol. 65:1991;1099-1104.
52. Xia Y.-P., Lai M. M. C. Oligomerization of hepatitis delta antigen is required for both thetranstrans. J. Virol. 66:1992;6641-6648.
53. pro. J. Virol. 71:1997;1220-1226.
54. Yalamanchili P., Harris K., Wimmer E., Dasgupta A. Inhibition of basal transcription by poliovirus: A virus-encoded protease (3Cpro) inhibits formation of TBP-TATA box complexin vitro. J. Virol. 70:1996;2922-2929.
55. Zenzie-Gregory B., Khachi A., Garraway I. P., Smale S. T. Mechanism of initiator-mediated transcription: Evidence for a functional interaction between the TATA-binding protein and DNA in the absence of a specific recognition sequence. Mol. Cell. Biol. 13:1993;3841-3849.
56. 1. Genes Dev. 11:1997;1605-1617.